Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Clinical trial NCT01800695 · COMPLETED
Trial details
- NCT number
- NCT01800695
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-02
- Primary completion
- 2017-06-19
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.